We are live on ! Find out more
MESO

Mesoblast

35 hedge funds and large institutions have $1.63M invested in Mesoblast in 2023 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 12 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

18% more call options, than puts

Call options by funds: $915K | Put options by funds: $773K

0.03% less ownership

Funds ownership: 0.11%0.08% (-0.03%)

19% less funds holding

Funds holding: 4335 (-8)

33% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 12

62% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 13

77% less capital invested

Capital invested by funds: $7M → $1.63M (-$5.37M)

Holders
35
Holders Change
-8
Holders Change %
-18.6%
% of All Funds
0.55%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
8
Reduced
12
Closed
13
Calls
$915K
Puts
$773K
Net Calls
+$142K
Net Calls Change
-$1.31M

MESO Hedge Fund Activity: Q3 2023 in Review

35 of the 6,310 institutional investors tracked by Wall St. Rank reported a position in Mesoblast (MESO) for Q3 2023, worth a combined $1.63M — down 77% from $7M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of MESO and 5 opened new positions — a net loss of 8 holders — while 12 trimmed existing stakes and 8 added.

The largest buyer was Prosperity Wealth Management, opening a new position worth an estimated $153K. The largest seller was Group One Trading, cutting an estimated $440K.

  • 35 institutional investors held Mesoblast (MESO) as of Q3 2023, down from 43 in Q2 2023.
  • Funds reported $1.63M of Mesoblast stock for Q3 2023, down 77% quarter-over-quarter.
  • 5 funds opened new Mesoblast positions in Q3 2023 and 13 closed out, a net change of -8 holders.
  • The largest Mesoblast buyer in Q3 2023 was Prosperity Wealth Management, an estimated $153K added.
  • The largest Mesoblast seller in Q3 2023 was Group One Trading, an estimated $440K sold.

Based on aggregated 13F filings for Q3 2023.